Dana Goldman is Director of the Roybal Center for Health Policy Simulation, and Director of the Leonard D. Schaeffer Center for Health Policy and Economics. Dana Goldman is a Professor and the Norman Topping Chair in Medicine and Public Policy at the University of Southern California. Until Fall 2009, he held RAND's Distinguished Chair in Health Economics and directed RAND's program in Economics, Finance, and Organization. He is also an Adjunct Professor of Health Services and Radiology at UCLA. In addition, Dana is an adjunct professor at both the David Geffen School of Medicine at UCLA and the UCLA School of Public Health. His research interests combine applied microeconomics and medical issues, with a special interest in the role that medical technology and health insurance play in determining health-related outcomes. See Dana's CV and publications.
Christine Eibner is an economist at the RAND Corporation and in the RAND Center for Military Health Policy Research. She specializes in applied econometrics and cost analyses. Her current research focuses on health disparity; employer-sponsored insurance; military medical policy; and modeling the effect of health care policy changes on costs, insurance coverage, and other outcomes. Her research in military health policy has focused on TRICARE, operational readiness of Department of Defense medical providers, and the economic costs of mental illness resulting from combat.
Shinyi Wu is Associate Director of the Roybal Center for Health Policy Simulation. She is also an assistant professor of the Daniel J. Epstein Department of Industrial and Systems Engineering
at University of Southern California
, and an affiliated faculty of the Pardee RAND Graduate School
. Her research focuses on application of quality improvement and assessment methods, decision analysis and simulation modeling, and cost-effectiveness analysis to improve health care delivery and health policy.
See Shinyi's CV and publications
Geoffrey Joyce is Associate Professor in Clinical Pharmacy and Pharmaceutical Economics & Policy in the School of Pharmacy at the University of Southern California. He is also a senior economist at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. Dr. Joyce is Co-Director of the UCLA-RAND Health Services Research Training Program, and Adjunct Associate Professor at the UCLA School of Public Health. He has particular interest and experience in the costs of delivering health care, with an emphasis on the impact of benefit design on drug costs, utilization, and adherence. See Geoffrey’s CV and publications
Darius Lakdawalla is an Associate Professor in the University of Southern California (USC) School of Policy, Planning, and Development (SPPD), and Director of Research at the USC Schaeffer Center for Health Policy and Economics. He is the former Director of Research at the Bing Center for Health Economics at the RAND Corporation. His research focuses on the economic determinants of health and human capital and their impact on aggregate trends in health and development.
See Darius's CV and publications
Pierre-Carl Michaud is an economist at the RAND Corporation and in the RAND Center for the Study of Aging. In addition to the economics of aging, his research interests include labor economics, health economics and applied econometrics. See Pierre-Carl’s CV and publications.
Neeraj Sood, PhD is Director of International Programs at the Leonard D. Schaeffer Center for Health Policy and Economics and Associate Professor at the Titus Family Department of Clinical Pharmacy, Pharmaceutical Economics & Policy at USC. His research focuses on health economics and health policy research, with an emphasis on outlier payment policies for the inpatient rehabilitation facility prospective payment system, the role of payment generosity on resource use for acute care patients, the effects of insurance on HIV-related mortality and the role of price regulation in health and life insurance markets.
See Neeraj's CV and publications
Yuhui Zheng, Ph.D., is a Postdoctoral Research Fellow at the National Bureau of
Economic Research. Her research interests include health economics, health service
research, health policy, and pharmacoeconomics. Her previous work has focuses on
prescription drug cost sharing and drug utilization, specialty drug, economics of
obesity, economics of disease prevention, and geographic variations in medical spending.